AVROBIO INC
AVROBIO INC logo
AVRO

AVROBIO INC (AVRO)

$0.8891.94%

Market is closed
– opens on 8 PM, 06 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.85
Day's Range
$0.89
$0.56
52-Week Range
$4.29
1 month return34.72%
3 month return2.27%
1 year return75.64%
5 year return97.15%

Company Information

AVROBIO's vision is to bring personalized gene therapy to the world. The company aims to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone. Its ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. AVROBIO is powered by its industry leading plato® gene therapy platform, its foundation designed to deliver gene therapy worldwide. The company is headquartered in Cambridge, Mass., with an office in Toronto, Ontario.
OrganizationAVROBIO INC
Employees122
CEOMr. Geoff MacKay BSc
IndustryHealth Technology

Analyst Recommendation

based on 8 analysts ratings

Buy
87%
Buy
12%
Hold
0%
Sell

Based on 8 Wall street analysts offering stock ratings for AVROBIO INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 336.45%

Current

$0.89

Target

$3.88

Recommendation Trend

Based on 8 analyst

Current1M Ago3M Ago
Buy
7
11
11
Hold
1
4
4
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
38.2M
Book Value
$2.24
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.81
Wall Street Target Price
3.88

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.39
Enterprise Value
-62587618
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.59

Technicals

Beta
1.57
50 Day MA
0.71
200 Day MA
0.98

Institutional Holdings

GMT Capital Corp

7.98%

K2 PRINCIPAL FUND LP

6.26%

JPMorgan Chase & Co

4.84%

BlackRock Inc

4.58%

Renaissance Technologies Corp

3.55%

Vanguard Group Inc

2.64%

Discover more

Frequently Asked Questions

What is AVROBIO INC share price today?

Can Indians buy AVROBIO INC shares?

How can I buy AVROBIO INC shares from India?

Can Fractional shares of AVROBIO INC be purchased?

What are the documents required to start investing in AVROBIO INC stocks?

What are today’s High and Low prices of AVROBIO INC?

What are today’s traded volumes of AVROBIO INC?

What is today’s market capitalisation of AVROBIO INC?

What is the 52 Week High and Low Range of AVROBIO INC?

How much percentage AVROBIO INC is down from its 52 Week High?

How much percentage AVROBIO INC is up from its 52 Week low?

What are the historical returns of AVROBIO INC?

Who is the Chief Executive Officer (CEO) of AVROBIO INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*